Quantitative Brain Volume Correlates of Neuropsychological and Neuropsychiatric Measures in Adults Living with HIV Receiving Antiretroviral Therapy: A 0.35-T MRI Study

Background: Cognitive, functional, psychological and sleep-related difficulties remain clinically relevant in people living with HIV (PLWH) receiving antiretroviral therapy (ART), but their relationship with macroscopic brain volume is incompletely characterised in African cohorts. Objective: To determine relationships between quantitative global and regional MRI brain volumes and neuropsychological and neuropsychiatric measures among adults living with HIV receiving ART. Methods: This cross-sectional analysis included 65 PLWH, of whom 60 had usable volumetric MRI data. Structural MRI was acquired using a 0.35-T GE SIGNA Ovation scanner and processed with an FSL-based pipeline incorporating SUSAN, BET, FAST and FIRST. Twenty-two MRI measures were correlated with five continuous outcomes (PAOFI, CTADL, CES-D, STAI-Trait and PSQI), yielding 110 Spearman correlations; pairwise sample sizes ranged from 56 to 60. Benjamini–Hochberg false-discovery-rate correction was applied across all tests. Results: Six correlations reached nominal p < .05, but none survived correction: adjusted white matter–CTADL (ρ = -.30, p = .018, q = .672), left thalamus–CTADL (ρ = .27, p = .039, q = .811), right globus pallidus–CTADL (ρ = .35, p = .006, q = .425), left hippocampus–CTADL (ρ = .26, p = .043, q = .811), brainstem–CTADL (ρ = .34, p = .008, q = .425), and left nucleus accumbens–STAI-Trait (ρ = .27, p = .044, q = .811). No PAOFI, CES-D or PSQI correlation reached nominal significance. Conclusion: Quantitative brain volumes showed several modest nominal relationships, mainly with everyday functioning, but no association remained statistically significant after multiple-comparison correction. The findings are exploratory and require replication in larger, longitudinal cohorts with formal low-field validation and higher-field comparison.

HIV; brain volumetry; neuropsychological measures; everyday functioning; sleep quality; anxiety; subcortical volume; low-field MRI; 0.35 T; Nigeria

1. Anazodo, U. C., Ng, J. J., Ehiogu, B., Obungoloch, J., Fatade, A., Mutsaerts, H. J. M. M., Secca, M. F., Diop, M., Opadele, A., Alexander, D. C., Dada, M. O., Ogbole, G., Nunes, R., Figueiredo, P., Figini, M., Aribisala, B., Awojoyogbe, B. O., Aduluwa, H., Sprenger, C., & Dako, F. (2023). A framework for advancing sustainable magnetic resonance imaging access in Africa. NMR in Biomedicine, 36(3), e4846. https://doi.org/10.1002/nbm.4846 [Google Scholar] [Crossref]

2. Ances, B. M., Ortega, M., Vaida, F., Heaps, J., & Paul, R. (2012). Independent effects of HIV, aging, and HAART on brain volumetric measures. Journal of Acquired Immune Deficiency Syndromes, 59(5), 469-477. https://doi.org/10.1097/QAI.0b013e318249db17 [Google Scholar] [Crossref]

3. Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., Gisslen, M., Grant, I., Heaton, R. K., Joseph, J., Marder, K., Marra, C. M., McArthur, J. C., Nunn, M., Price, R. W., & Wojna, V. E. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69(18), 1789-1799. https://doi.org/10.1212/01.WNL.0000287431.88679.8B [Google Scholar] [Crossref]

4. Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B (Methodological), 57(1), 289-300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x [Google Scholar] [Crossref]

5. Buysse, D. J., Reynolds, C. F., III, Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Research, 28(2), 193-213. https://doi.org/10.1016/0165-1781(89)90047-4 [Google Scholar] [Crossref]

6. Chelune, G. J., Heaton, R. K., & Lehman, R. A. W. (1986). Neuropsychological and personality correlates of patients' complaints of disability. In G. Goldstein & R. E. Tarter (Eds.), Advances in clinical neuropsychology (Vol. 3, pp. 95-126). Plenum Press. https://doi.org/10.1007/978-1-4613-2211-5_4 [Google Scholar] [Crossref]

7. Chien, A., Wu, T., Lau, C.-Y., Pandya, D., Wiebold, A., Agan, B., Snow, J., Smith, B., Nath, A., & Nair, G. (2024). White and gray matter changes are associated with neurocognitive decline in HIV infection. Annals of Neurology, 95(5), 941-950. https://doi.org/10.1002/ana.26896 [Google Scholar] [Crossref]

8. Dreyer, A. J., Nightingale, S., Heaps-Woodruff, J. M., Henry, M., Gouse, H., Paul, R. H., Thomas, K. G. F., & Joska, J. A. (2021). Rates of cognitive impairment in a South African cohort of people with HIV: Variation by definitional criteria and lack of association with neuroimaging biomarkers. Journal of NeuroVirology, 27(4), 579-594. https://doi.org/10.1007/s13365-021-00993-x [Google Scholar] [Crossref]

9. Gouse, H., Thomas, K. G. F., Masson, C. J., Henry, M., Joska, J. A., Cysique, L. A., Ling, S., Ye, X., Liu, J., & Robbins, R. N. (2025). Generating fair, reliable, and accurate neuropsychological test norms for people with HIV in a low- or middle-income country. Journal of NeuroVirology, 31(1), 41-55. https://doi.org/10.1007/s13365-024-01235-6 [Google Scholar] [Crossref]

10. Hasford, F., Mumuni, A. N., Trauernicht, C., Ige, T. A., Inkoom, S., Okeji, M., Nathaniel, E. U., Toutaoui, N. K., Geraldo, M., Amadou, K., Uwizeyimana, C., Samba, O. N., Attalla, E. M., Kebede, E., Edou-Mbo, G., Okoko, E. O., Alghazirr, Z. O., Pokoo-Aikins, M., Sosu, E. K., & Stoeva, M. (2022). A review of MRI studies in Africa with special focus on quantitative MRI: Historical development, current status and the role of medical physicists. Physica Medica, 103, 46-58. https://doi.org/10.1016/j.ejmp.2022.09.016 [Google Scholar] [Crossref]

11. Heaps, J. M., Joska, J., Hoare, J., Ortega, M., Agrawal, A., Seedat, S., Ances, B. M., Stein, D. J., & Paul, R. (2012). Neuroimaging markers of human immunodeficiency virus infection in South Africa. Journal of NeuroVirology, 18(3), 151-156. https://doi.org/10.1007/s13365-012-0090-5 [Google Scholar] [Crossref]

12. Heaps, J. M., Sithinamsuwan, P., Paul, R., Lerdlum, S., Pothisri, M., Clifford, D., Tipsuk, S., Catella, S., Busovaca, E., Fletcher, J. L., Raudabaugh, B., Ratto-Kim, S., Valcour, V., & Ananworanich, J. (2015). Association between brain volumes and HAND in cART-naive HIV-positive individuals from Thailand. Journal of NeuroVirology, 21(2), 105-112. https://doi.org/10.1007/s13365-014-0309-8 [Google Scholar] [Crossref]

13. Heaton, R. K., Clifford, D. B., Franklin, D. R., Jr., Woods, S. P., Ake, C., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J. H., Rivera-Mindt, M., Vigil, O. R., Taylor, M. J., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., & Grant, I. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: The CHARTER study. Neurology, 75(23), 2087-2096. https://doi.org/10.1212/WNL.0b013e318200d727 [Google Scholar] [Crossref]

14. Heaton, R. K., Franklin, D. R., Ellis, R. J., McCutchan, J. A., Letendre, S. L., LeBlanc, S., Corkran, S. H., Duarte, N. A., Clifford, D. B., Woods, S. P., Collier, A. C., Marra, C. M., Morgello, S., Rivera Mindt, M., Taylor, M. J., Marcotte, T. D., Atkinson, J. H., Wolfson, T., Gelman, B. B., & Grant, I. (2011). HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. Journal of NeuroVirology, 17(1), 3-16. https://doi.org/10.1007/s13365-010-0006-1 [Google Scholar] [Crossref]

15. Heaton, R. K., Marcotte, T. D., Rivera Mindt, M., Sadek, J., Moore, D. J., Bentley, H., McCutchan, J. A., Reicks, C., Grant, I., & HNRC Group. (2004). The impact of HIV-associated neuropsychological impairment on everyday functioning. Journal of the International Neuropsychological Society, 10(3), 317-331. https://doi.org/10.1017/S1355617704102130 [Google Scholar] [Crossref]

16. Kennedy, J., Cooley, S. A., Roman Fox, J., Lopez, L., & Ances, B. M. (2026). Longitudinal changes in cognition and brain imaging in persons with human immunodeficiency virus. The Journal of Infectious Diseases, 233(5), e1173-e1180. https://doi.org/10.1093/infdis/jiag029 [Google Scholar] [Crossref]

17. Lee, S., Oh, J. W., Park, K. M., Ahn, J. Y., Lee, S., & Lee, E. (2024). The prevalence and moderating factors of sleep disturbances in people living with HIV: A systematic review and meta-analysis. Scientific Reports, 14, 14817. https://doi.org/10.1038/s41598-024-65713-x [Google Scholar] [Crossref]

18. Li, R., Liu, G., Aili, X., Zhang, M., Li, H., & Lu, J. (2025). Characteristics of cortical thickness in treated HIV-infected individuals with and without cognitive impairment. European Journal of Medical Research, 30, 281. https://doi.org/10.1186/s40001-025-02555-x [Google Scholar] [Crossref]

19. Malone, I. B., Leung, K. K., Clegg, S., Barnes, J., Whitwell, J. L., Ashburner, J., Fox, N. C., & Ridgway, G. R. (2015). Accurate automatic estimation of total intracranial volume: A nuisance variable with less nuisance. NeuroImage, 104, 366-372. https://doi.org/10.1016/j.neuroimage.2014.09.034 [Google Scholar] [Crossref]

20. Marques, J. P., Simonis, F. F. J., & Webb, A. G. (2019). Low-field MRI: An MR physics perspective. Journal of Magnetic Resonance Imaging, 49(6), 1528-1542. https://doi.org/10.1002/jmri.26637 [Google Scholar] [Crossref]

21. McMahan, C., Dietrich, D. K., Horne, E. F., Kelly, E., Geannopoulos, K., Julnes, P. S. S., Ham, L., Santamaria, U., Lau, C.-Y., Wu, T., Hsieh, H.-C., Ganesan, A., Berjohn, C., Kapetanovic, S., Reich, D. S., Nair, G., Snow, J., Agan, B. K., Nath, A., & Smith, B. R. (2023). Neurocognitive dysfunction with neuronal injury in people with HIV on long-duration antiretroviral therapy. Neurology, 100(24), e2466-e2476. https://doi.org/10.1212/WNL.0000000000207339 [Google Scholar] [Crossref]

22. Melese, M., Mengistie, B. A., Delie, A. M., Limenh, L. W., Worku, N. K., Fenta, E. T., Hailu, M., Abie, A., Mehari, M. G., Eseyneh, T., Esubalew, D., & Abuhay, H. W. (2024). Poor sleep quality and its associated factors among HIV/AIDS patients living in sub-Saharan African countries: A systematic review and meta-analysis. Scientific Reports, 14, 16955. https://doi.org/10.1038/s41598-024-68074-7 [Google Scholar] [Crossref]

23. Mudra Rakshasa-Loots, A., Diteko, G., Dowell, N. G., Ronen, I., & Vera, J. H. (2025). Neuroimmunometabolic alterations and severity of depressive symptoms in people with HIV: An exploratory diffusion-weighted MRS study. Brain and Neuroscience Advances, 9, 1-11. https://doi.org/10.1177/23982128251335792 [Google Scholar] [Crossref]

24. Murata, S., Hagiwara, A., Kaga, H., Someya, Y., Nemoto, K., Goto, M., Kamagata, K., Irie, R., Hori, M., Andica, C., Wada, A., Kumamaru, K. K., Shimoji, K., Otsuka, Y., Hoshito, H., Tamura, Y., Kawamori, R., Watada, H., & Aoki, S. (2022). Comparison of brain volume measurements made with 0.3- and 3-T MR imaging. Magnetic Resonance in Medical Sciences, 21(3), 517-524. https://doi.org/10.2463/mrms.tn.2020-0034 [Google Scholar] [Crossref]

25. Nichols, M. J., Gates, T. M., Soares, J. R., Moffat, K. J., Rae, C. D., Brew, B. J., & Cysique, L. A. (2019). Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection. AIDS, 33(1), 55-66. https://doi.org/10.1097/QAD.0000000000002042 [Google Scholar] [Crossref]

26. Nightingale, S., Ances, B., Cinque, P., Dravid, A., Dreyer, A. J., Gisslen, M., Joska, J. A., Kwasa, J., Meyer, A.-C., Mpongo, N., Nakasujja, N., Pebody, R., Pozniak, A., Price, R. W., Sandford, C., Saylor, D., Thomas, K. G. F., Underwood, J., Vera, J. H., & Winston, A. (2023). Cognitive impairment in people living with HIV: Consensus recommendations for a new approach. Nature Reviews Neurology, 19(7), 424-433. https://doi.org/10.1038/s41582-023-00813-2 [Google Scholar] [Crossref]

27. Nightingale, S., Dreyer, A. J., Saylor, D., Gisslen, M., Winston, A., & Joska, J. A. (2021). Moving on from HAND: Why we need new criteria for cognitive impairment in persons living with human immunodeficiency virus and a proposed way forward. Clinical Infectious Diseases, 73(6), 1113-1118. https://doi.org/10.1093/cid/ciab366 [Google Scholar] [Crossref]

28. Nir, T. M., Fouche, J.-P., Ananworanich, J., Ances, B. M., Boban, J., et al. (2021). Association of immunosuppression and viral load with subcortical brain volume in an international sample of people living with HIV. JAMA Network Open, 4(1), e2031190. https://doi.org/10.1001/jamanetworkopen.2020.31190 [Google Scholar] [Crossref]

29. O'Connor, E. E., Sullivan, E. V., Chang, L., Hammoud, D. A., Wilson, T. W., Ragin, A. B., Meade, C. S., Coughlin, J., & Ances, B. M. (2023). Imaging of brain structural and functional effects in people with human immunodeficiency virus. The Journal of Infectious Diseases, 227(Suppl 1), S16-S29. https://doi.org/10.1093/infdis/jiac387 [Google Scholar] [Crossref]

30. Patenaude, B., Smith, S. M., Kennedy, D. N., & Jenkinson, M. (2011). A Bayesian model of shape and appearance for subcortical brain segmentation. NeuroImage, 56(3), 907-922. https://doi.org/10.1016/j.neuroimage.2011.02.046 [Google Scholar] [Crossref]

31. Peric, R., Kozic, D., Brkic, S., Lendak, D., Ostojic, J., Bugarski Ignjatovic, V., & Boban, J. (2025). Reduction in brain parenchymal volume correlates with depression and cognitive decline in HIV-positive males. Medicina, 61(4), 632. https://doi.org/10.3390/medicina61040632 [Google Scholar] [Crossref]

32. Pfefferbaum, A., Zahr, N. M., Sassoon, S. A., Fama, R., Saranathan, M., Pohl, K. M., & Sullivan, E. V. (2024). Aging, HIV infection, and alcohol exert synergist effects on regional thalamic volumes resulting in functional impairment. NeuroImage: Clinical, 44, 103684. https://doi.org/10.1016/j.nicl.2024.103684 [Google Scholar] [Crossref]

33. Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385-401. https://doi.org/10.1177/014662167700100306 [Google Scholar] [Crossref]

34. Samardzija, A., Selvaganesan, K., Zhang, H. Z., Sun, H., Sun, C., Ha, Y., Galiana, G., & Constable, R. T. (2024). Low-field, low-cost, point-of-care magnetic resonance imaging. Annual Review of Biomedical Engineering, 26, 67-91. https://doi.org/10.1146/annurev-bioeng-110122-022903 [Google Scholar] [Crossref]

35. Shan, Y., Sun, G., Ji, J., Li, Z., Chen, X., Zhang, X., Ma, Y., Zhang, Y., Zhang, T., & Zhang, Y. (2024). Brain function abnormalities and neuroinflammation in people living with HIV-associated anxiety disorders. Frontiers in Psychiatry, 15, 1336233. https://doi.org/10.3389/fpsyt.2024.1336233 [Google Scholar] [Crossref]

36. Smith, S. M., Jenkinson, M., Woolrich, M. W., Beckmann, C. F., Behrens, T. E. J., Johansen-Berg, H., Bannister, P. R., De Luca, M., Drobnjak, I., Flitney, D. E., Niazy, R. K., Saunders, J., Vickers, J., Zhang, Y., De Stefano, N., Brady, J. M., & Matthews, P. M. (2004). Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage, 23(Suppl 1), S208-S219. https://doi.org/10.1016/j.neuroimage.2004.07.051 [Google Scholar] [Crossref]

37. Sorby-Adams, A., Keo, M., Guo, J., Daly, D., Ahern, R., Zachary, K., Robbins, G., Gandhi, R. T., Sveinsson, B., de Havenon, A., Sheth, K. N., Rapalino, O., Iglesias Gonzales, J. E., Kimberly, W. T., & Mukerji, S. S. (2026). Portable low-field magnetic resonance imaging in people with human immunodeficiency virus. Annals of Clinical and Translational Neurology, 13(3), 537-546. https://doi.org/10.1002/acn3.70237 [Google Scholar] [Crossref]

38. Spielberger, C. D., Gorsuch, R. L., Lushene, R., Vagg, P. R., & Jacobs, G. A. (1983). Manual for the State-Trait Anxiety Inventory (Form Y). Consulting Psychologists Press. [Google Scholar] [Crossref]

39. Uddin, M. N., Singh, M. V., Faiyaz, A., Szczepankiewicz, F., Nilsson, M., Boodoo, Z. D., Sutton, K. R., Tivarus, M. E., Zhong, J., Wang, L., Qiu, X., Weber, M. T., & Schifitto, G. (2024). Tensor-valued diffusion MRI detects brain microstructural abnormalities in HIV infected individuals with cognitive impairment. Scientific Reports, 14, 28839. https://doi.org/10.1038/s41598-024-80372-8 [Google Scholar] [Crossref]

40. Voevodskaya, O., Simmons, A., Nordenskjold, R., Kullberg, J., Ahlstrom, H., Lind, L., Wahlund, L.-O., Larsson, E.-M., Westman, E., & Alzheimer's Disease Neuroimaging Initiative. (2014). The effects of intracranial volume adjustment approaches on multiple regional MRI volumes in healthy aging and Alzheimer's disease. Frontiers in Aging Neuroscience, 6, 264. https://doi.org/10.3389/fnagi.2014.00264 [Google Scholar] [Crossref]

41. Winston, A., & Spudich, S. (2020). Cognitive disorders in people living with HIV. The Lancet HIV, 7(7), e504-e513. https://doi.org/10.1016/S2352-3018(20)30107-7 [Google Scholar] [Crossref]

42. Zhou, Z., Wang, W., Li, H., Shi, Y., Zhao, L., Lu, Y., Wei, X., & Li, H. (2025). Decoding HIV-associated neurocognitive disorders: A new perspective from multimodal connectomics. Frontiers in Neurology, 16, 1467175. https://doi.org/10.3389/fneur.2025.1467175 [Google Scholar] [Crossref]